CRAMP Activators
CRAMP activators encompass a range of chemicals that indirectly stimulate the production or activity of CRAMP by activating immune and cellular response pathways. These activators primarily work by enhancing the expression of CRAMP through the activation of various signaling pathways. For instance, Cholecalciferol, through its activation of the VDR, directly upregulates CRAMP gene expression. Similarly, immune stimulants like lipopolysaccharides (LPS) and IL-22 enhance CRAMP expression by activating NF-κB and other related signaling pathways in immune and epithelial cells.
Other compounds like butyrate and retinoic acid activate immune responses and gene expression, leading to increased CRAMP production. Butyrate, through its action as a histone deacetylase inhibitor, affects chromatin remodeling, which can influence CRAMP expression. Retinoic acid acts through retinoic acid receptor-mediated signaling, affecting CRAMP expression. Additionally, immune response activators such as zymosan, PMA, and Poly(I:C) stimulate various Toll-like receptors or signaling pathways like PKC, leading to an upregulation of CRAMP production. The commonality among these chemicals is their ability to activate immune and inflammatory responses, which are crucial for the regulation of CRAMP, making them indirect activators of this antimicrobial peptide.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol enhances CRAMP expression by activating the Vitamin D receptor (VDR), which can bind to the promoter region of the CRAMP gene, leading to its upregulation. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS, a component of Gram-negative bacterial cell walls, can stimulate immune cells, leading to the activation of NF-κB pathway, which in turn can enhance CRAMP expression. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyrate, a short-chain fatty acid produced by gut microbiota, can upregulate CRAMP expression, possibly through histone deacetylase inhibition and subsequent chromatin remodeling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of Vitamin A, can modulate immune responses and potentially increase CRAMP expression through retinoic acid receptor-mediated signaling. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
Zymosan, a polysaccharide from yeast cell walls, activates immune responses and can stimulate CRAMP production through Toll-like receptor signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, an activator of protein kinase C (PKC), can enhance CRAMP expression in certain cell types, possibly through PKC-mediated signaling pathways. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded, a synthetic analog of double-stranded RNA, can activate immune responses, leading to increased CRAMP production through Toll-like receptor 3 signaling. | ||||||